Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases.
Journal: Immunotherapy
Published: December 21, 2021
Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseases.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: December 13, 2018
Response to the Letter to the Editor Regarding "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials".
Journal: Journal of clinical immunology
Published: August 08, 2017
Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.
Journal: Journal of clinical immunology
Published: July 18, 2017
Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency.
Journal: Journal of clinical immunology
Published: October 28, 2016
Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.
Journal: Journal of clinical immunology
Published: May 30, 2016
20% subcutaneous immunoglobulin dosed biweekly for primary immunodeficiency.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: April 08, 2016
Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.
Journal: Journal of clinical immunology
Published: March 18, 2016
Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency.
Journal: Journal of clinical immunology
Published: December 15, 2015
Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.
Journal: Clinical and experimental immunology
Published: October 10, 2014
Last Updated: 09/26/2026